SMTL ID : 6oqn.2 (1 other biounit)

Crystal structure of Mcl1 with inhibitor 7

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.70 Å

Oligo State

monomer

Ligands

1 x N0P: (4S)-5'-chloro-2',3',7,8,9,10,11,12-octahydro-3H,5H,14H-spiro[1,19-etheno-16lambda~6~-[1,4]oxazepino[3,4-i][1,4,5,10]oxathiadiazacyclohexadecine-4,1'-indene]-16,16,18(15H,17H)-trione(Non-covalent)

N0P.1: 14 residues within 4Å: Chain A: H.54, A.57, F.58, L.76, V.79, M.80, V.83, F.84, R.93, T.96, L.97, F.100, G.101, L.120 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:A.57, A:F.58, A:V.79, A:V.83, A:V.83, A:T.96, A:L.97 Hydrogen bonds: A:R.93 Water bridges: A:T.96 pi-Stacking: A:F.100

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Caenepeel, S. et al., AMG 176, a Selective MCL1 Inhibitor, Is Effective in Hematologic Cancer Models Alone and in Combination with Established Therapies. Cancer Discov (2018)

Release Date

2019-05-15

Peptides

Induced myeloid leukemia cell differentiation protein Mcl-1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Induced myeloid leukemia cell differentiation protein Mcl-1

Related Entries With Identical Sequence